The risk of asthma exacerbation after reducing inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trials

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 4, 2014, Pages 510-516

  Hagan, J B ^a   Samant, S A ^a   Volcheck, G W ^a   Li, J T ^a   Hagan, C R ^b   Erwin, P J ^a   Rank, M A ^c  

^a MAYO CLINIC   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

anti asthmatic agents; asthma; clinical trial; glucocorticoids; step down

Indexed keywords

CORTICOSTEROID;

ARTICLE; ASTHMA; ATTRIBUTABLE RISK; DISEASE DURATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; EMERGENCY WARD; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIAL; GLUCOCORTICOIDS; STEP DOWN;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84895527766     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12368     Document Type: Article

References (17)

1. National Institutes of Health. Factbook Fiscal Year 2011. Available at: http://www.nhlbi.nih.gov/about/factbook/FactBook2011.pdf. Last Accessed 24 May 2013.
2. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program. Available at: http://www.nhlbi.nih.gov/about/naepp/. Last Accessed 24 May 2013.
3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2011 update. Available at: http://www.ginasthma.org/uploads/users/ files/GINA-Report-2011.pdf. Last Accessed 24 May 2013.
4. Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, Zeiger RS, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012; 367: 904-912.
5. Rank MA, Hagan JB, Park MA, Podjasek JC, Samant SA, Volcheck GV, et al. The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systemic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2013; 131: 724-729.
6. Brozek JL, Kraft M, Krishnan JA, Cloutier MM, Lazarus SC, Li JT, et al. Long-acting β2-agonist step-off in patients with controlled asthma. Arch Int Med 2012; 172: 1365-1375.
7. Moher D, Liberati A, Telzlaff J,. Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: B2535.
8. Martinez FD, Chinchilli VM, Morgan WJ, Boehmer SJ, Lemanske RF Jr, Mauger DT, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomized, double-blind, placebo-controlled trial. Lancet 2011; 377: 650-657.
9. Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org.
10. Juniper EF, Kline PA, Vanzieleghem MA, Hargreave FE,. Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991; 87: 483-489.
11. ZuWallack RL, Rosen JP, Cohen L, Rachelefsky GS, Hong H Jr, Goldsobel AB, et al. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control. J Allergy Clin Immunol 1997; 99: 278-285.
12. Visser ML, Postma DS, Arends LR, de Vries TW, Duiverman EJ, Brand PL,. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Am J Respir Crit Care Med 2001; 164: 2073-2077.
13. Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC,. Stepping down inhaled corticosteroids in asthma: a randomized controlled trial. BMJ 2003; 326: 1115.
14. Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007; 356: 2040-2052.
15. Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M, et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA 2012; 308: 987-997.
16. Busse WW, Morgan WJ, Taggart V, Togias A,. Standardizing asthma outcomes in clinical research: report of the asthma outcomes workshop. J Allergy Clin Immunol 2012; 129: S1-S141.
17. Yawn BP, Wollan PC, Bertram SL, Lowe D, Butterfield JH, Bonde D, et al. Asthma treatment in a population-based cohort: putting step-up and step-down treatment changes in context. Mayo Clin Proc 2007; 82: 414-421.